| Current management of hepatocellular carcinoma AM Crissien, C Frenette Gastroenterology & hepatology 10 (3), 153, 2014 | 248 | 2014 |
| Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma AG Singal, NE Rich, N Mehta, AD Branch, A Pillai, M Hoteit, M Volk, ... Gastroenterology 157 (5), 1253-1263. e2, 2019 | 169 | 2019 |
| Direct-acting antiviral therapy not associated with recurrence of hepatocellular carcinoma in a multicenter North American cohort study AG Singal, NE Rich, N Mehta, A Branch, A Pillai, M Hoteit, M Volk, ... Gastroenterology 156 (6), 1683-1692. e1, 2019 | 162 | 2019 |
| Management of sorafenib-related adverse events: a clinician’s perspective MS Brose, CT Frenette, SM Keefe, SM Stein Seminars in Oncology 41, S1-S16, 2014 | 150 | 2014 |
| Excellent outcomes of liver transplantation following down-staging of hepatocellular carcinoma to within Milan criteria: a multicenter study N Mehta, J Guy, CT Frenette, JL Dodge, RW Osorio, WB Minteer, ... Clinical Gastroenterology and Hepatology 16 (6), 955-964, 2018 | 139 | 2018 |
| Updates in the management of hepatocellular carcinoma R Wong, C Frenette Gastroenterology & hepatology 7 (1), 16, 2011 | 136 | 2011 |
| Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network RS Brown Jr, JG O'Leary, KR Reddy, A Kuo, GJ Morelli, JR Burton Jr, ... Liver Transplantation 22 (1), 24-33, 2016 | 125 | 2016 |
| Liver transplantation for hepatocellular carcinoma: management after the transplant EC Verna, YA Patel, A Aggarwal, AP Desai, C Frenette, AA Pillai, R Salgia, ... American Journal of Transplantation 20 (2), 333-347, 2020 | 119 | 2020 |
| A practical guideline for hepatocellular carcinoma screening in patients at risk CT Frenette, AJ Isaacson, I Bargellini, S Saab, AG Singal Mayo Clinic Proceedings: Innovations, Quality & Outcomes 3 (3), 302-310, 2019 | 91 | 2019 |
| Emricasan improves liver function in patients with cirrhosis and high model for end-stage liver disease scores compared with placebo CT Frenette, G Morelli, ML Shiffman, RT Frederick, RA Rubin, MB Fallon, ... Clinical Gastroenterology and Hepatology 17 (4), 774-783. e4, 2019 | 89 | 2019 |
| A practical review of cytomegalovirus in gastroenterology and hepatology AY Fakhreddine, CT Frenette, GG Konijeti Gastroenterology research and practice 2019 (1), 6156581, 2019 | 86 | 2019 |
| The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis RJ Wong, R Gish, T Frederick, N Bzowej, C Frenette Journal of clinical gastroenterology 46 (2), 155-161, 2012 | 86 | 2012 |
| Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial JM Llovet, M Kudo, P Merle, T Meyer, S Qin, M Ikeda, R Xu, J Edeline, ... The Lancet Oncology 24 (12), 1399-1410, 2023 | 81 | 2023 |
| Management of hepatocellular carcinoma: current status and future directions JS Au, CT Frenette Gut and Liver 9 (4), 437, 2015 | 76 | 2015 |
| Morphometry confirms fibrosis regression from sustained virologic response to direct‐acting antivirals for hepatitis C JJ Pan, F Bao, E Du, C Skillin, CT Frenette, J Waalen, L Alaparthi, ... Hepatology Communications 2 (11), 1320-1330, 2018 | 74 | 2018 |
| Downstaging outcomes for hepatocellular carcinoma: results from the multicenter evaluation of reduction in tumor size before liver transplantation (MERITS-LT) consortium N Mehta, C Frenette, P Tabrizian, M Hoteit, J Guy, N Parikh, TT Ghaziani, ... Gastroenterology 161 (5), 1502-1512, 2021 | 73 | 2021 |
| Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications C Frenette, R Gish World journal of gastroenterology: WJG 18 (6), 498, 2012 | 73 | 2012 |
| Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series RJ Wong, R Gish, T Frederick, N Bzowej, C Frenette Digestive diseases and sciences 56, 578-585, 2011 | 73 | 2011 |
| Race/ethnicity-specific disparities in hepatocellular carcinoma stage at diagnosis and its impact on receipt of curative therapies J Ha, M Yan, M Aguilar, M Tana, B Liu, CT Frenette, T Bhuket, RJ Wong Journal of clinical gastroenterology 50 (5), 423-430, 2016 | 69 | 2016 |
| Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma MS Bhangoo, DR Karnani, PN Hein, H Giap, H Knowles, C Issa, ... Journal of Gastrointestinal Oncology 6 (5), 469, 2015 | 67 | 2015 |
